Sees FY25 adjusted EBITDA $15M-$17M. The company said, “For full year 2025, the Company expects its revenue to be in the range of $235.0 million to $242.0 million, representing growth of 15% to 18% over 2024 revenue. The Company also expects its annual set deployment to be approximately $15.0 million and expects to generate $15.0 million to $17.0 million of adjusted EBITDA for full year 2025.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KIDS:
- OrthoPediatrics reports Q4 adjusted EPS (29c), consensus (26c)
- KIDS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- OrthoPediatrics announces distribution agreement with Thrive Orthopedics
- OrthoPediatrics Highlights Growth Strategy in Presentations
- OrthoPediatrics sees Q4 revenue $52.7M, consensus $50.73M